A Phase I, Single-centre, Open-label, Partly Randomised, Cross-over Single Dose Study in Healthy Volunteers to Evaluate the Absolute Pulmonary Bioavailability of AZD8683 When Administered Inhaled Via a New Dry Powder Inhaler and Via Turbuhaler.

Trial Profile

A Phase I, Single-centre, Open-label, Partly Randomised, Cross-over Single Dose Study in Healthy Volunteers to Evaluate the Absolute Pulmonary Bioavailability of AZD8683 When Administered Inhaled Via a New Dry Powder Inhaler and Via Turbuhaler.

Withdrawn prior to enrolment
Phase of Trial: Phase I

Latest Information Update: 18 Dec 2012

At a glance

  • Drugs AZD 8683 (Primary) ; AZD 8683 (Primary) ; AZD 8683 (Primary)
  • Indications Chronic obstructive pulmonary disease
  • Focus Pharmacokinetics
  • Most Recent Events

    • 18 Dec 2012 Status changed from suspended to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
    • 03 Dec 2012 Status changed from not yet recruiting to suspended as reported by ClinicalTrials.gov.
    • 22 Aug 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top